Insisting upon intravenous immunoglobulin therapy in polymiositis case after severe hemolytic anemia;Poursuite du traitement d'une polymyosite par les immunoglobulines intraveineuses polyvalentes malgré la survenue d'une anémie hémolytique sévère

Transfusion Clinique et Biologique

Volumn 8, Issue 2, 2001, Pages 94-99

  Ballot Brossier, C ^a   Mortelecque, R ^a   Sinegre M ^a   Marceau, A ^a   Dauriat, G ^a   Courtois, F ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Hemolysis; Intravenous immunoglobulin; Monitoring; Polymyositis; Reinfusion

Indexed keywords

CELL RECEPTOR; HEMAGGLUTININ; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ALLOIMMUNIZATION; ARTICLE; CASE REPORT; DRUG MEGADOSE; DRUG MONITORING; FEMALE; HEMOLYTIC ANEMIA; HUMAN; MACROPHAGE; POLYMYOSITIS;

EID: 17744362654     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(01)00109-4     Document Type: Article

References (17)

1. Tolérance des Ig IV polyvalentes. Investigation
2. Hemolysis due to high-dose intravenous gammaglobulin treatment for patients with idiopathic thrombocytopenic purpura
3. Immune complex-like moieties in immunoglobulin for intravainous use (IVIg) bind complement and enhance phagocytis of human erythrocytes
4. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration
5. Massive intravascular hemolysis associated with intravenous immoglobulin in bone marrow transplant recipients
6. Hemolytic anemia associated with intravenous immunoglobulin
7. Hemolytic anemia following intravenous gamma globulin administration
8. Hemolysis following intravenous immune globulin therapy
9. Hemolytic anemia following high-dose intravenous immunoglobulin administration
10. Experiance with intraveinous immunoglobulin for treatment of inflammatory myopathies
11. Les immunoglobulines intraveineuses dans les polymyosites et les dermatomyosites
12. Étude prospective des manifestations d'hémolyse liées à l'utilisation d'IgIV au cours du syndrome de Guillain Barré (SGB) et de la myasthénie (M)
13. Adverse effects of intravenous immunoglobulin
14. Hemolysis after high dose intraveinous Ig
15. Erythrocytes from young but elderly donors can bind and degrade immune complex - And antibody - Bound C3 in vitro
16. Isoantibodies in immunoglobulin for intravenous use may cause erythrocyte sequestration